Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)
Jingquan Huang, Qiulin Wu, David A. Geller, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma
Deming Li, Ting Zhang, Ye Guo, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 12
Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy
Guangtan Du, Cunmiao Dou, Peng Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights
Farzam Vaziri, Tahereh Setayesh, Ying Hu, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 5
Role of T cell metabolism in brain tumor development: a genetic and metabolic approach
Bo Yang, Zhenyu Li, Peiliang Li, et al.
BMC Neurology (2025) Vol. 25, Iss. 1
Open Access
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
Siqi Ren, Yinping Zhang, Xingyue Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tumor Prognostic Risk Model Related to Monocytes/Macrophages in Hepatocellular Carcinoma Based on Machine Learning and Multi-Omics
Xinliang Wan, Yan Zou, Qichun Zhou, et al.
Biological Procedures Online (2025) Vol. 27, Iss. 1
Open Access
SEPT9 and PAI-1 are immunohistochemical biomarkers of the hepatocellular carcinoma immune microenvironment
Eundong Park, Xin Wang, Nusret Bekir Subasi, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Alpha-Fetoprotein (AFP) biosensors
Nava Moghadasian Niaki, Faezeh Hatefnia, Mohammad Heidari, et al.
Clinica Chimica Acta (2025) Vol. 573, pp. 120293-120293
Closed Access
Macrophages Orchestrate the Liver Tumor Microenvironment
Valeria Quaranta, Costanza Ballarò, Gianluigi Giannelli
Cancers (2024) Vol. 16, Iss. 9, pp. 1772-1772
Open Access | Times Cited: 3
Role of Nutraceuticals in Counteracting Inflammation in In Vitro Macrophages Obtained from Childhood Cancer Survivors
Alessandra Di Paola, Maria Maddalena Marrapodi, Elvira Pota, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 714-714
Open Access | Times Cited: 2
LncRNA CRNDE promotes hepatoma cell proliferation by regulating the metabolic reprogramming of M2 macrophages via ERK pathway
Lin Chao, Tao Jiang, E Changyong, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
TREM1+ tumor-associated macrophages secrete CCL7 to promote hepatocellular carcinoma metastasis
Simin Huang, Longguang He, Yufei Zhao, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 1
LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis
Banglun Pan, Shuling Shen, Jun Zhao, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 9, pp. 1827-1841
Closed Access | Times Cited: 1
Construction and validation of a prognostic signature based on microvascular invasion and immune-related genes in hepatocellular carcinoma
Hao Li, Lixue Qiao, Minyu Kong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers
Qinlan Xu, Dong Shao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
V-ATPase in cancer: mechanistic insights and therapeutic potentials
Tingting Chen, Xiaotan Lin, Shuo Lu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Macrophage niche imprinting as a determinant of macrophage identity and function
Małgorzata Kloc, Marta Hałasa, Rafik M. Ghobrial
Cellular Immunology (2024) Vol. 399-400, pp. 104825-104825
Closed Access
Bioinformatics combined with single-cell analysis reveals the molecular mechanism of pyroptosis in hepatocellular carcinoma
Wei Luo, Junxia Wang, Hongfei Wang, et al.
Research Square (Research Square) (2024)
Open Access
Genetic association of tertiary lymphoid structure-related gene signatures with HCC based on Mendelian randomization and machine learning and construction of prognosis model
Pu Lei, Xiaoyan Zhang, Pu Cheng, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113594-113594
Open Access
Metabolic Crossroad Between Macrophages and Cancer Cells: Overview of Hepatocellular Carcinoma
Anna Santarsiero, Vittoria Infantino, Dominga Iacobazzi, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2684-2684
Open Access
The Role of Macrophages in Hepatocellular Carcinoma and Their Therapeutic Potential
Megan E. Bannister, Devnandan Chatterjee, Shishir Shetty, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13167-13167
Open Access
Page 1

Scroll to top